Skip to main content

Plasma ascorbic acid: measurement, stability and clinical utility revisited.

Chung WY, Chung JK, Szeto YT, Tomlinson B, Benzie IF

Publication: Clin Biochem (2001) • Vol 34 • Page 623-7PMID: 11849621View on PubMed

Purpose

The purpose of this paper was to determine if the colorimetric Ferric Reducing/Antioxidant and Ascorbic Acid (FRASC) assay is a suitable alternative to HPLC for measuring plasma ascorbic acid. In addition, various anticoagulants and storage conditions were examined.

Conclusion

Using FRASC to detect levels of ascorbic acid in plasma specimens gave results similar to those obtained with HPLC. Ascorbic acid was most stable when heparin was used as an anticoagulant. Storage for up to 10 days at -70 degrees C did not significantly impact ascorbic acid concentration, while higher storage temperatures resulted in significant losses. Artificial light and prolonged exposure of ascorbic acid to erythrocytes did not affect ascorbic acid stability.

Studies (3)

Purpose

The purpose of this study was to compare the precision and sensitivity of HPLC and FRASC when measuring levels of ascorbic acid in heparinated plasma specimens. Plasma was stored at -70 degrees C prior to analysis.

Summary of Findings

Both HPLC and FRASC showed a high level of precision and sensitivity (detection limits of 1.0 umol/L and 3.0 umol/L, respectively), with respect to ascorbic acid detection. No significant differences were found between the two detection methods when matched plasma specimens were subjected to each method on the same day.

  • Biospecimens

    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    Small moleculeHPLC
    Small moleculeClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    HPLC SpecificTechnology platform
    FRASC